Radiation To Tumors Articles & Analysis
22 news found
BNCT is a targeted radiation cancer therapy in which neutron beams interact with a boron-bearing compound, taken up selectively by tumors, to create DNA-damaging alpha particles within the tumor cells, sparing neighboring, healthy tissue. BNCT has the potential to deliver highly effective, cell-localized radiation therapy to ...
The study published as part of the special issue of Cancers “Novel Techniques and Technology for Treatment of Brain Tumors”, reports that Spermidine/spermine N1-acetyltransferase 1 (SAT1) inhibition using an ionizable lipid nanoparticle-based siRNA delivery system appears to provide a safe and effective method to sensitizing GB cells to radiation and ...
In fact, according to the National Brain Tumor Society, the five-year survival rate for GBM is only 6.8 percent with an average survival time of eight months. ...
ByCervoMed
BNCT is a targeted radiation cancer therapy in which neutron beams destroy only boron compound-bearing tumors without destroying neighboring normal tissue. BNCT has the potential to deliver highly effective and cell-localized radiation therapy to treat tumors with minimal impact on the patient’s quality of life compared to ...
” Proton therapy, a highly advanced form of radiation therapy, targets tumors with greater precision than traditional x-ray-based radiotherapy and can reduce the amount of unnecessary radiation exposure to vulnerable healthy tissue and organs. ...
While the treatment of HNSCC depends on multiple tumor and patient-related factors, the three main treatments are surgical resection, radiation therapy and chemotherapy. Patients with early-stage lymph node-negative tumors are generally treated with surgical resection, but treatment for those with more advanced lymph node-positive ...
Session Title: Poster Q&A 05 - Session 05 - Genitourinary Cancer, Hematology Malignancies, and Sarcoma and Cutaneous Tumors Presentation Time: 1:30 PM CT Location: McCormick Place West, Outside Room W375 Presentation No.: 2532 Category: Genitourinary Cancer Title: Randomized Trial of Conventional vs Conventional plus Fluciclovine (18F) PET/CT-Guided Post-Prostatectomy ...
We believe each advisor contributes to our patient centric mission by offering expansive patient care expertise along with deep translational research experience in radiation biology and tumor hypoxia. Up to 90 % of solid tumors are hypoxic, which can contribute to multi-modal treatment resistance, increased risk of metastasis, and decreased ...
ByCervoMed
This energy is concentrated directly on the tumor while minimizing radiation dose to surrounding healthy tissue. ...
They implanted the FDA-cleared GammaTile therapy in a 44-year-old patient with a malignant brain tumor. The current standard of care for patients with operable malignant glioma tumors is surgical removal of the tumor followed by radiation and chemotherapy. ...
Conducted by a joint team of breast surgeons and radiation oncologists at Brown University and Tufts Medical Center, the analysis compared the repeatable delineation of the tumor bed after lumpectomy for radiation therapy planning and treatment as well as safety and effectiveness. ...
GT Medical Technologies received this accolade in recognition of GammaTile® Therapy, its Surgically Targeted Radiation Therapy (STaRT), developed to prevent or significantly delay the recurrence of operable brain tumors. "We are honored to receive recognition for this innovative technology that overcomes the limitations of current brain ...
TAE Life Sciences (TLS), a biological-targeting radiation therapy company developing next-generation boron neutron capture therapy (BNCT), today announced a partnership with BEC GmbH (BEC) to incorporate a customized, robotic patient positioning system as part of its Alphabeam™ Neutron System for the high-precision radiation treatment of ...
Mehee Choi, director of Medical Affairs at GT Medical Technologies, will discuss new data in patients with recurrent glioblastoma (GBM), and access-to-care for patients with resectable brain tumors. GammaTile is an implantable radiation therapy consisting of bioresorbable collagen tiles embedded with Cesium-131 sources provided by Isoray, Inc. ...
The previous standard of care for patients with operable brain tumors is the surgical removal of the tumor followed by adjuvant therapy, including radiation and chemotherapy. ...
The previous standard of care for patients with operable brain tumors is the surgical removal of the tumor followed by adjuvant therapy, including radiation and chemotherapy. ...
However, given the surgical site often lies in soft tissue, exact identification of the native tumor bed can present some difficulty for radiation planning. The surgical and radiation oncology team at Providence Mission Hospital (Mission Viejo, Ca) elected to use a novel tumor bed marker called VeraForm for a sarcomatoid ...
Given the location and extent of disease, placing a radiopaque filament to help target the adjuvant radiation is extremely helpful, both for allowing better delivery of radiation to the exact tumor bed and limiting radiation spray to other structures such as the heart, lungs and surrounding muscles. In this case, it’s ...
And what if the knowledge gleaned from the preop imaging could be combined with the surgeon’s intraop observations to localize the tumor bed in the most accurate way possible for the radiation oncologist? ...
Edinburgh Molecular Imaging Ltd, a company developing theragnostic agents targeting cancer, today announces the closing of a £3.1 million financing, which will be used to advance new molecular targeted systemic radiotherapy agents, EMT-100 and EMT-101 to be ready for clinic development. Current investors and one new investor supported the round. EMT-100 and EMT-101 have been developed as ...